Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

164.82 +9.65 (+6.22%)
Streaming Delayed Price Updated: 2:05 PM EDT, Jul 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact from the 2026 Medicare drug price cuts, easing initial industry concerns. 
Via Benzinga
Q3’s Rising Stars: 3 Dow Stocks for Your Must-Watch List
These Dow stocks to watch have all been beaten down over the past year or more but are now poised for a rebound. 
Via InvestorPlace
Topics Stocks
A Closer Look at 14 Analyst Recommendations For Johnson & Johnson
Via Benzinga
Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
The healthcare sector, represented by the XLV ETF, has seen a resurgence, breaking out of a multi-year consolidation phase and surging almost 3% in July. 
Via MarketBeat
Topics ETFs
Johnson & Johnson Unusual Options Activity For July 29
Via Benzinga
Looking Into Johnson & Johnson's Recent Short Interest
Via Benzinga
Check Out What Whales Are Doing With JNJ
Via Benzinga
Why the dividend investor may take a look at NYSE:JNJ.
Uncovering Dividend Opportunities with JOHNSON & JOHNSON (NYSE:JNJ). 
Via Chartmill
Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference
From Johnson & Johnson
Via Business Wire
Stocks Going Ex Dividend In August 2024
A short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors. 
Via Talk Markets
7 Long-Term Stocks to Buy on the Dip: July 2024
As investors begin to rotate out of tech stocks, it's time to look at these long-term stocks that are trading at an inviting discount. 
Via InvestorPlace
Could Johnson & Johnson's Troubles With Talc Lawsuits Finally Be Coming to an End?
Is it safe to buy Johnson & Johnson stock now? 
Via The Motley Fool
Topics Lawsuit
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Courts, Congress Likely to Stand in Way of J&J’s Third Texas Two-Step Plan
From Beasley Allen Law Firm
Via Business Wire
FINAL DEADLINE: Ovarian Cancer Victims Have Until 5pm ET Today to Vote on Approximately $8 Billion J&J Talc Compensation Plan
From Ad Hoc Group of Counsel
Via Business Wire
3 Stocks Reeling From Ruined Reputations: Can They Recover?
Unforced errors by each of these controversial stocks has sullied their reputations and recovering them will not be easy or cheap. 
Via InvestorPlace
3 Beaten-Down Value Stocks Poised for a Massive Comeback: July 2024
Investors might want to consider these beaten-down value stocks, each of which looks poised for a turnaround in the year's second half. 
Via InvestorPlace
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Guggenheim Partners initiated coverage on Alumis, highlighting its lead asset ESK-001, a TYK2 inhibitor for plaque psoriasis and systemic lupus erythematosus. With upcoming Phase 3 trials and no JAK... 
Via Benzinga
Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
Via Benzinga
Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
President Biden's decision to drop out may harm healthcare and create market volatility. Kamala Harris could defend his record and support Medicare for All. 
Via Benzinga
Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
Intuitive Surgical is an AI stock that you can buy and hold forever. Its business is health care; it makes profits, and health care is growing 
Via MarketBeat
Topics Artificial Intelligence
Lawyers for Ovarian Cancer Victims Urge NO Vote on J&J’s Latest Bankruptcy Plan
From Beasley Allen Law Firm
Via Business Wire
Four Stocks To Watch This Week - Monday, July 22
It's possible that following the Crowdstrike/Microsoft outage last week, big investor over-reliance on the tech mega-caps could be under review in the medium term. 
Via Talk Markets
After Disappointing Data, Johnson & Johnson Halts Developing Epilepsy Drug Candidate
Addex Therapeutics announces Janssen Pharmaceuticals, a Johnson & Johnson unit, has halted ADX71149 development for epilepsy after Phase 2 data. 
Via Benzinga
Johnson & Johnson Faces Legal Hurdle In Talc Lawsuit Battle
Johnson & Johnson's attempt to disqualify Beasley Allen from representing plaintiffs in talc cancer cases is denied by a New Jersey judge, impacting the company's strategy to settle claims through... 
Via Benzinga
Topics Lawsuit
Stocks See Mixed Reactions Amid Geopolitical Tensions And Earnings Surprises
Concerns were exacerbated by comments from former President Trump, raising fears of geopolitical tensions. 
Via Talk Markets
Topics Government
This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now.
This fund has a basket of growth, income, and value stocks. 
Via The Motley Fool
Topics ETFs
MarketBeat Week in Review – 7/15 - 7/19
Stocks took a breather to close the week, but corporate earnings and the next reading on the PCE index will help determine what direction the market moves next 
Via MarketBeat
Topics Economy
7 Consumer Staples Stocks to Buy at a 52-Week Low in July
If the long-awaited sector rotation is happening, it’s time to look at these undervalued consumer staples stocks. 
Via InvestorPlace
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.